JAYMIE ALVAREZ: Open Payments
NPI 1689161119 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$150 in 7 payments from 7 companies in 2025. Trend: 2023 $174 · 2024 $388 · 2025 $150
Food & beverage: $150
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 1 | $30 |
| Janssen Pharmaceuticals, Inc | 1 | $29 |
| Neurocrine BioSciences, Inc. | 1 | $26 |
| ABBVIE INC. | 1 | $22 |
| Lundbeck LLC | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
| Almatica Pharma LLC | 1 | $14 |
Products named: ARISTADA, SPRAVATO, INGREZZA, VRAYLAR, REXULTI, ABILIFY ASIMTUFII, LOREEV XR.
Industry payments across NV — which companies pay providers there.
